TScan Therapeutics TCRX
NASDAQ TCRX
$0.32 +0.00 (+0.95%)
At close: Oct 1, 2026 · 4:00 PM EDT

TScan Therapeutics (TCRX) Operating Margin (2020 - 2026)

Updated

TScan Therapeutics' Operating Margin came in at -2901.33% for Q2 2026, down 1644.73 percentage points from -1256.60% a year earlier but up 65.98 percentage points from the prior quarter.

Analysis

TScan Therapeutics (TCRX) Operating Margin (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, TScan Therapeutics reported Operating Margin of -1695.15%, up 376.92 percentage points year-over-year; for FY2025, it came in at -1315.38%, up 3472.30 percentage points from FY2024.

  • Operating Margin carries a five-year change of +1102.41 percentage points (FY2020 to FY2025).
  • Going back by year, Operating Margin was -4787.68% in FY2024 (-4343.68 pp), -444.00% in FY2023 (+48.32 pp), -492.32% in FY2022 (-12.68 pp) and -479.65% in FY2021 (+1938.14 pp).
  • The five-year range for quarterly Operating Margin is -6364.55% (Q2 2024) to -296.17% (Q4 2023).
  • Year-over-year, Operating Margin increased in four of the last eight quarters, with an average year-over-year change of +570.84 percentage points.
  • The fastest year-over-year change in Operating Margin over five years came in Q2 2025 (a gain of 5107.95 percentage points), and the weakest in Q2 2024 (a drop of 5582.79 percentage points).
  • Business Quant data shows TCRX's Operating Margin at -2967.31% (Q1 2026), -929.41% (Q4 2025) and -1475.59% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 28.21%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 37.86%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -3.52%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 32.97%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 20.57%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 34.95%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -133.21%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 37.40%
10 TScan Therapeutics 40.28 Mn 40.28 Mn - -2,901.33%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,901.33%
Mar 31, 2026 -2,967.31%
Dec 31, 2025 -929.41%
Sep 30, 2025 -1,475.59%
Jun 30, 2025 -1,256.60%
Mar 31, 2025 -1,669.74%
Dec 31, 2024 -5,520.60%
Sep 30, 2024 -3,109.82%
Jun 30, 2024 -6,364.55%
Mar 31, 2024 -5,542.93%
Dec 31, 2023 -296.17%
Sep 30, 2023 -636.69%
Jun 30, 2023 -781.77%
Mar 31, 2023 -334.31%
Dec 31, 2022 -602.55%
Sep 30, 2022 -492.95%
Jun 30, 2022 -375.89%
Mar 31, 2022 -535.02%
Dec 31, 2021 -497.62%
Sep 30, 2021 -656.80%
API Access

TScan Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=TCRX&period=max&api_key=YOUR_API_KEY